 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CAMBRIDGE, MA / ACCESSWIRE / September 14, 2023 / Allarity Therapeutics (NASDAQ:ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer...

Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including Positive Publications In PLOS One And At ASCO, Positive Early Data From An Ongoing Clinical Trial, And External Partnering For Its DRP(R) Technology

Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps? Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps? PR Newswire NEW...

Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps?

- The DRP-Dovitinib companion diagnostic demonstrated an ability to identify advanced renal cell carcinoma patients that have improved clinical benefit from dovitinib treatment, as compared to unselected patients BOSTON (August 30, 2023) Allarity Therapeutics, Inc. (Allarity or the Company) (Nasdaq...

PLOS ONE Publishes Data on Allarity Therapeutics' DRP(R) Companion Diagnostic for Dovitinib

Allarity Therapeutics, Inc. (NASDAQ:ALLR  Get Free Report) was the recipient of a large growth in short interest in the month of August. As of August 15th, there was short interest totalling...

Allarity Therapeutics, Inc. (NASDAQ:ALLR) Sees Large Increase in Short Interest

Thinking about buying stock in Oncolytics Biotech, INVO Bioscience, Troika Media Group, Allarity Therapeutics, or Barnes & Noble Education? Thinking about buying stock in Oncolytics Biotech, INVO Bioscience, Troika Media Group, Allarity Therapeutics, or Barnes & Noble Education? PR...

Thinking about buying stock in Oncolytics Biotech, INVO Bioscience, Troika Media Group, Allarity Therapeutics, or Barnes & Noble Education?

Allarity Therapeutics, Inc. (NASDAQ:ALLR  Get Free Report) saw a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 63,000 shares, an increase of 176.3% from the June 30th total of 22,800 shares. Based on an average trading volume of...

Short Interest in Allarity Therapeutics, Inc. (NASDAQ:ALLR) Rises By 176.3%

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. ( Allarity or the Company ) (NASDAQ: ALLR). Such investors...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Allarity Therapeutics, Inc. - ALLR

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allarity Therapeutics, Inc. - ALLR SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allarity Therapeutics, Inc. - ALLR

New appointments bring therapeutic development expertise and proven leadership to support continued progress of Allaritys multiple oncology clinical programs BOSTON (July 24, 2023) Allarity Therapeutics, Inc. (Allarity or the Company), a clinical-stage pharmaceutical company developing novel ...

Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives

NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. (Allarity or the Company) (NASDAQ:ALLR). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...

Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company was founded on April 4, 2021 and is headquartered in Boston, MA.

Watchers	3,628
52-Wk Low	$0.7178
52-Wk High	$1,890.00

Market Cap	$377,700.00
Volume (M)	1,841.00
52-Wk High	$1,890.00
52-Wk Low	$0.7178

ALLR Allarity Therapeutics Inc

About

Feed

News

Fundamentals